Clinical trial
Retro-prospective Evaluation of the Clinical Safety and Effectiveness of Hydrophilic Acrylic Intraocular Lens (509)
NCT04789538 is registered in ClinicalTrials.gov with Carl Zeiss Meditec AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retro-prospective Evaluation of the Clinical Safety and Effectiveness of Hydrophilic Acrylic Intraocular Lens (509)
- Lead sponsor
- Carl Zeiss Meditec AG
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2021
- Completion date
- April 1, 2022
- Enrollment
- 328 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cataract senile